Parabilis Medicines, Inc. (PBLS) Stock

Parabilis Medicines, Inc. (PBLS) is a Healthcare stock trading at $31.31 (as of 2026-07-24), with a market capitalization of $3.48B. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Valuation — source: SEC EDGAR (first-party)
Price$31.31
Market Cap$3.48B
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.2
Industry P/E (Pharmaceutical Products)17.0
Company
SectorHealthcare
IndustryPharmaceutical Products

Related Companies (SIC 2834 / Pharmaceutical Products; 8 closest by market cap; US-domiciled)

  • Catalyst Pharmaceuticals, Inc. (CPRX)
  • Tango Therapeutics, Inc. (TNGX)
  • Arcus Biosciences, Inc. (RCUS)
  • Organon & Co. (OGN)
  • Alumis Inc. Common Stock (ALMS)
  • Arcutis Biotherapeutics, Inc. (ARQT)
  • Enliven Therapeutics, Inc. (ELVN)
  • IDEAYA Biosciences, Inc. (IDYA)
PBLS earnings history · PBLS institutional & insider holders · PBLS KPIs & operating metrics · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-07-24.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.